Skip to main navigation Skip to search Skip to main content

Balloon-Expandable Versus Self-Expanding Valves in Patients With Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement

  • Kimberley Iris Hemelrijk
  • , Gijs Matthias Broeze
  • , Hugo Marc Aarts
  • , Erika Muñoz Garcia
  • , Didier Tchétché
  • , Fabio Sandoli de Brito
  • , Marco Barbanti
  • , Ran Kornowski
  • , Azeem Latib
  • , Augusto D’ Onofrio
  • , Flavio Ribichini
  • , Belen Cid
  • , Nicolas Dumonteil
  • , Alexandre Abizaid
  • , Samantha Sartori
  • , Paola D’Errigo
  • , Giuseppe Tarantini
  • , Cesar Federico Vigo
  • , Katia Orvin
  • , Matteo Pagnesi
  • Raquel del Valle-Fernandez, George Dangas, Roxana Mehran, Astrid Cornelia van Nieuwkerk, Ronak Delewi

Research output: Contribution to journal › Article › peer-review

Abstract

Transcatheter aortic valve replacement (TAVR) is a widely accepted treatment option for patients with severe aortic valve stenosis. However, approximately one-third of patients undergoing TAVR present with a small aortic annulus, which is associated with impaired valve performance. The primary objective of this study was to evaluate 2-year mortality after transfemoral TAVR in patients with a small aortic annulus (valve size ≤23 mm for balloon-expandable valves and ≤26 mm for self-expanding valves), comparing balloon-expandable with self-expanding valves. The CENTER2-study includes data from 25,771 patients undergoing TVR. Patients were propensity score-matched and compared on clinical outcomes. A total of 8,827 (37.2%) patients had a small aortic annulus. Mean age was 81.9 ± 6.3 years, 76.9% were female, and the median STS-PROM score was 4.8% (IQR 2.3 to 5.6). In the matched cohort of 2,692 patient pairs, patients receiving a balloon-expandable valve had higher rates of life-threatening bleeding at 30 days (3.6% vs 2.4%, p = 0.01) and two-year mortality (19.1% vs 15.3%, HR 1.23, 95% CI 1.07 to 1.43, p = 0.004). However, permanent pacemaker implantation was more frequent in patients receiving a self-expanding valve (21.6% vs 8.7%, p < 0.001). In conclusion, in this large real-world cohort of patients undergoing transfemoral TAVR, 37.2% of patients had a small aortic annulus. Patients with a small aortic annulus receiving a balloon-expandable valve had higher 2-year mortality rates. Patients receiving a self-expanding valve had higher rates of permanent pacemaker implantation.

Original languageEnglish
Pages (from-to)44-50
Number of pages7
JournalAmerican Journal of Cardiology
Volume274
DOIs
StatePublished - 1 Sep 2026

Keywords

  • TAVR
  • aortic stenosis
  • small aortic annulus

Fingerprint

Dive into the research topics of 'Balloon-Expandable Versus Self-Expanding Valves in Patients With Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement'. Together they form a unique fingerprint.

Cite this